Prosthetic Heart Valve Market, By Position Type (Aortic Valve, Mitral Valve, and Others), By Valve Type (Mechanical Valves, Tissue Valves, and Transcatheter Valves), By End User (Hospitals, Ambulatory Surgical Centres, Catheterization Laboratory, and Othe

Global prosthetic heart valve market is estimated to be valued at USD 14.76 Bn in 2025 and is expected to exhibit a CAGR of 11.7% during the forecast period (2025-2032). The prosthetic heart valve market has been witnessing steady growth over the past few years owing to the increasing prevalence of heart valve diseases and rising number of valve replacement surgeries. Prosthetic heart valves help in replacing damaged heart valves that do not function properly. There has been a substantial increase in the patient pool suffering from heart valve conditions such as mitral and aortic regurgitation or stenosis due to aging population and risk factors like smoking, obesity, and diabetes. Moreover, technological advancements in valve design from mechanical valves to bioprosthetic valves and rising healthcare expenditure have been contributing towards the growth of the prosthetic heart valve market globally. However, high cost of treatment remains a key concern inhibiting wider adoption.

Market Dynamics

Rising geriatric population base along with increasing burden of heart valve diseases across major countries act as the major growth drivers for the prosthetic heart valve market. As per estimates, over 16 million people suffer from valve diseases in the U.S. alone. The growing prevalence of obesity and diabetes which are major risk factors for developing valve defects supplement the market growth. Furthermore, introduction of technologically advanced, minimally invasive transcatheter heart valves as an alternative to conventional open-heart surgeries is gradually gaining adoption, bolstering the market revenues. However, prohibitively high costs associated with valve replacement surgeries limits widespread adoption, especially in developing regions. Stringent regulatory guidelines for new product approvals also impacts the market adversely. But ongoing R&D for developing affordable devices and enhanced technologies presents significant opportunities for prosthetic heart valve manufacturers over coming years.

Key Features of the Study

• This report provides an in-depth analysis of the global prosthetic heart valve market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global prosthetic heart valve market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology , TTK Healthcare Limited , Lepu Medical Technology Co. Ltd , Foldax, Inc. , Symetis SA , On-X Life Technologies, and Braile Biomedica.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global prosthetic heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prosthetic heart valve market.

Market Segmentation

• Position Type Insights (Revenue, USD Bn, 2020 - 2032)
• Aortic Valve
• Mitral Valve
• Others
• Valve Type Insights (Revenue, USD Bn, 2020 - 2032)
• Mechanical Valves
• Tissue Valves
• Transcatheter Valves
• End User Insights (Revenue, USD Bn, 2020 - 2032)
• Hospitals
• Ambulatory Surgical Centers
• Catheterization Laboratory
• Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Edwards Lifesciences Corporation
• Medtronic plc.
• Boston Scientific Corporation
• Abbott Laboratories
• LivaNova PLC
• CryoLife Inc.
• Braile Biomedica
• Colibri Heart Valve LLC
• JenaValve Technology Inc.
• TTK Healthcare Limited
• Lepu Medical Technology Co., Ltd
• Foldax, Inc.
• Symetis SA
• On-X Life Technologies
• Braile Biomedica

Show more